Resultados de la búsqueda 381-390 of 3207 for short-term detox programs
... short- and long-term outcomes. Safety will be ... stay, and readmission rates. Phase 1/2 ... Study findings may help researchers design more programs ...
Venetoclax may stop the growth of cancer cells by blocking Bcl-2, a protein needed for cancer cell survival. Giving venetoclax with ibrutinib and rituximab with ...
This phase Ib trial studies the side effects and best dose of a vaccine called H2NVAC before surgery in treating patients with HER2 expressing ductal carcinoma ...
The five year follow-up period will ensure robust ... time to progression, stage at progression ... center. Site recruitment and patient enrollment ...
Prostate cancer recurrence most often happens in the first five years after treatment. But it can happen at any time. It can occur after any type of treatment, ...
... time of routine tumor biopsy procedure, or clinically-indicated surgery. ... centers, worldwide. Patient Derived Preclinical Models. Rochester, Minn. The ...
The purpose of this research trail is to study the genetic alteration/mutation and immune profiling in surgical resected Non-small Cell Lung Cancer (NSCLC) ...
Mayo Clinic no respalda compañías ni productos. Las recaudaciones de los avisos comerciales financian nuestra misión sin fines de lucro.
Consulta estos éxitos de venta y ofertas especiales en libros y boletines informativos de Mayo Clinic Press.
¿Te gustaría hacer una donación deducible de impuestos y ser parte de una investigación de vanguardia y de una atención médica que transforma la medicina?